These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 21314022)
1. International workshop on adverse drug reactions and co-morbiditles in HIV and the Tenth International Congress on Drug Therapy in HIV Infection in Glasgow. Taylor J Posit Aware; 2011; 23(1):20-1. PubMed ID: 21314022 [No Abstract] [Full Text] [Related]
2. Key data from the 11th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV. Boehme RE; Cameron S Antivir Ther; 2009; 14(8):1195-208. PubMed ID: 20032550 [TBL] [Abstract][Full Text] [Related]
3. Drug reactions & lipodystrophy workshop. Coppedge B STEP Perspect; 1999; 99(3):17-8. PubMed ID: 11366865 [TBL] [Abstract][Full Text] [Related]
4. Sublime versus simple side effect stories (or, forget the adiponectin, just stop smoking). 5th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. July 8-11, 2003, Paris. Mascolini M IAPAC Mon; 2003 Oct; 9(10):242-8, 252-61. PubMed ID: 14696574 [No Abstract] [Full Text] [Related]
5. [HIV infection: antiretroviral therapy 1997. Consensus statement of the International AIDS Society-USA Panel]. Med Monatsschr Pharm; 1997 Dec; 20(12):343-6. PubMed ID: 9527604 [No Abstract] [Full Text] [Related]
6. [Kidney colic under Indinavir [correction of indiavir] therapy in HIV infection]. Junghanss BG Praxis (Bern 1994); 1997 Apr; 86(18):767-8. PubMed ID: 9244966 [No Abstract] [Full Text] [Related]
7. Report from the 11th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV. Treatment for patients with central fat accumulation. Currier J J Watch AIDS Clin Care; 2010 Mar; 22(3):21-2. PubMed ID: 20480623 [No Abstract] [Full Text] [Related]
8. Abstracts of the Tenth International Congress on Drug Therapy in HIV Infection. Glasgow, United Kingdom. November 7-11, 2010. J Int AIDS Soc; 2010; 13 Suppl 4():K13, O1-51, P1-237. PubMed ID: 21078210 [No Abstract] [Full Text] [Related]
9. [Emergencies in HIV infection]. Burckhardt B; Battegay M Ther Umsch; 1998 May; 55(5):295-301. PubMed ID: 9643127 [TBL] [Abstract][Full Text] [Related]
10. Hypersensitivity reactions to drugs in HIV-infected patients. Allergic evaluation and desensitization. Moreno-Ancillo A; López-Serrano MC Clin Exp Allergy; 1998 Sep; 28 Suppl 4():57-60. PubMed ID: 9761034 [No Abstract] [Full Text] [Related]
11. Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients. Núñez M; Soriano V J Hepatol; 2005 Mar; 42(3):290-2. PubMed ID: 15710208 [No Abstract] [Full Text] [Related]
12. Dermatologic manifestations of HIV infection. Maurer TA Top HIV Med; 2005 Dec-2006 Jan; 13(5):149-54. PubMed ID: 16377853 [TBL] [Abstract][Full Text] [Related]
13. Hyperlipidemia in HIV-infected patients: the protective effect of hepatitis C virus co-infection. Collazos J; Mayo J; Ibarra S; Cazallas J AIDS; 2003 Apr; 17(6):927-9. PubMed ID: 12660545 [No Abstract] [Full Text] [Related]
14. Anti-HIV agents. Once-daily anti-HIV therapy in people co-infected with TB. TreatmentUpdate; 2004; 16(3):4-5. PubMed ID: 17219607 [No Abstract] [Full Text] [Related]
15. Adverse events experienced by three children taking tenofovir and didanosine in combination. Hawkins S; Ball C HIV Med; 2007 Sep; 8(6):411. PubMed ID: 17661851 [No Abstract] [Full Text] [Related]
16. Diagnosis and management of HIV drug hypersensitivity. Davis CM; Shearer WT J Allergy Clin Immunol; 2008 Apr; 121(4):826-832.e5. PubMed ID: 18190954 [TBL] [Abstract][Full Text] [Related]
17. Severe neutropenia during therapy for concurrent primary human immunodeficiency virus and cytomegalovirus infections. Sutinen J; Ristola M; Suni J; Nuutinen H; Lähdevirta J Clin Infect Dis; 1999 Apr; 28(4):920-1. PubMed ID: 10825068 [No Abstract] [Full Text] [Related]
18. Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection. Yamamoto Y; Yasuoka A; Yasuoka C; Genka I; Teruya K; Kikuchi Y; Tachikawa N; Oka S Jpn J Infect Dis; 2000 Dec; 53(6):244-5. PubMed ID: 11227023 [No Abstract] [Full Text] [Related]
19. Beyond lipodystrophy: will toxicity issues ever outweigh the benefits of HAART? Vella S; Palmisano L J HIV Ther; 2003 May; 8(2):27-8. PubMed ID: 15587479 [No Abstract] [Full Text] [Related]
20. Management of antiretroviral treatment-related complications. Hoffman RM; Currier JS Infect Dis Clin North Am; 2007 Mar; 21(1):103-32, ix. PubMed ID: 17502232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]